Literature DB >> 30202345

Chronic Obstructive Pulmonary Disease.

Sean O'Reilly1.   

Abstract

COPD is a common, preventable, and treatable disease characterized by persistent airflow obstruction associated with enhanced inflammation in the airways and the lung in response to noxious particles or gases. Clinical history and pulmonary function testing are necessary for accurate diagnosis. While exposure to tobacco smoke remains a common cause, other etiologies and underlying genetic predisposition play significant roles. Treatment options are numerous and should be individualized based on symptoms and exacerbation frequency.

Entities:  

Keywords:  COPD; FEV1; GOLD; exacerbation

Year:  2016        PMID: 30202345      PMCID: PMC6125102          DOI: 10.1177/1559827616656593

Source DB:  PubMed          Journal:  Am J Lifestyle Med        ISSN: 1559-8276


  80 in total

1.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.

Authors:  L Davies; R M Angus; P M Calverley
Journal:  Lancet       Date:  1999-08-07       Impact factor: 79.321

Review 2.  Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?

Authors:  Juan José Soler-Cataluña; Roberto Rodriguez-Roisin
Journal:  COPD       Date:  2010-08       Impact factor: 2.409

Review 3.  Hospital at home for acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Elisabeth Jeppesen; Kjetil G Brurberg; Gunn E Vist; Jadwiga A Wedzicha; John J Wright; Michael Greenstone; Julia A E Walters
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

4.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

Authors:  J J Soler-Cataluña; M A Martínez-García; P Román Sánchez; E Salcedo; M Navarro; R Ochando
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

Review 5.  Mortality in COPD: Role of comorbidities.

Authors:  D D Sin; N R Anthonisen; J B Soriano; A G Agusti
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

6.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

7.  Complex chronic comorbidities of COPD.

Authors:  L M Fabbri; F Luppi; B Beghé; K F Rabe
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

8.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.

Authors:  G C Donaldson; T A R Seemungal; A Bhowmik; J A Wedzicha
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

9.  A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial.

Authors:  Vincent S Fan; J Michael Gaziano; Robert Lew; Jean Bourbeau; Sandra G Adams; Sarah Leatherman; Soe Soe Thwin; Grant D Huang; Richard Robbins; Peruvemba S Sriram; Amir Sharafkhaneh; M Jeffery Mador; George Sarosi; Ralph J Panos; Padmashri Rastogi; Todd H Wagner; Steven A Mazzuca; Colleen Shannon; Cindy Colling; Matthew H Liang; James K Stoller; Louis Fiore; Dennis E Niewoehner
Journal:  Ann Intern Med       Date:  2012-05-15       Impact factor: 25.391

10.  Daily step count predicts acute exacerbations in a US cohort with COPD.

Authors:  Marilyn L Moy; Merilee Teylan; Nicole A Weston; David R Gagnon; Eric Garshick
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

View more
  1 in total

Review 1.  Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases.

Authors:  Yinghan Chan; Sachin Kumar Singh; Monica Gulati; Sheetu Wadhwa; Parteek Prasher; Deepak Kumar; Avvaru Praveen Kumar; Gaurav Gupta; Gowthamarajan Kuppusamy; Mehra Haghi; Brian Gregory George Oliver; Jon Adams; Dinesh Kumar Chellappan; Kamal Dua
Journal:  J Drug Deliv Sci Technol       Date:  2022-06-23       Impact factor: 5.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.